Fox News: Teva & ANP Announce That ATL/TV1102, a Novel Drug for the Treatment of Relapsing Remitting Multiple Sclerosis (RRMS), Demonstrated Significant Reduction in Disease Activity

[riky]

Teva & ANP Announce That ATL/TV1102, a Novel Drug for the Treatment of Relapsing Remitting Multiple Sclerosis (RRMS), Demonstrated Significant Reduction in Disease Activity
     

-- Results Demonstrate Impressive Reduction of Disease Activity as
                          Early as 8 Weeks -

    -- Teva Intends to Conduct Additional Pre-Clinical and Clinical
 Research Before Continuing to a Phase III Study with this Unique and
                         Promising Molecule --<img src="You are not allowed to view links. Register or Login" height="1" width="1"/><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
     

You are not allowed to view links. Register or Login